Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Potential $3 million Rueckert, $875K Stoll, Keck $87.5 and Simpson $87.5 or about $4 million from insiders. Failure is rotten in any form but the ethics crowd have to watch this unfold
Right now though, this action of form 4's is what has been one of the big desires. It has been done exactly correct. Buying at an unnecessary premium makes no sense, who can find fault? I will backup I think my 394 at market with 3000 at 1.75, not as optimum as the insiders who knew the picture best
Unless she really wanted more than 50,000 shares, she would be an idiot to buy more than 100 shares. Just the stark fact
500 is in the press release. The really big boy here can buy about $3 million worth, gives me modest but not overwhelming confidence
success changes everything, fact 101
continued failure, ugh
I can only say the company knows it needs to do better than in the past, big offering may can make that happen
No, try to keep my eyes open for enlightenment
If insiders go all the way, there will be minimal shares likely out of recent financing, sticking to around 30 million shares max if $50 million gross ahead
Essentially options/market price stocks are bought past tense. So for executing the rights/options my best guess is all 4 will buy with the 2 bod members going with BIG BUCKS
That is all over, quality bio, been on bod since 2014 as I recall. It was a naïve donation in the past. Of course IF at 500 to 1, Stoll would be in also for $875,000
If it had been me I would have advocated higher than $1.75, but don't know the feedback story. That is history. I believe Simpson has always been success driven despite all we know, maybe my middle name is Pollyanna. I think the biggest risk is still coming in at substantially less than $27 million but I am thinking a middle of the road for me rights move of going for 3000 shares.
At this point in time, I consider this as good a future hint as could be hoped for. The company is not secretly throwing in the towel imo, Simpson instead seems daily to be keeping things moving forward
Why pay higher prices for over 3000 shares which means $2,000 extra bucks, when you have all the knowledge about rights deal. Think about it
There has to be a point in the man's mind to buy a lot more than 100 shares well above $1.75, it is wild to think $3 million but who would likely be more interested than this gentleman. If the gross is less than $27 million on the offering, my guess is following offering the price would have little upside above $2 even, for possibly months. I don't mind any scenario that provides stability.
I am guessing gross can equal $10 million at least, still think $50 million as unlikely.
If your guess is different, can you describe
The 500 figure was eliminated apparently, but I suspect the ratio will be at least 500 to 1, unless fully subscribed. My best guess is he is seriously considering 500 to 1 as a rights execution. He has what appears a good reputation, seriously doubt "FAKE"
Every 1 share gets you rights to purchase up to 500 shares, unless oversubscribed. So an honorable bio historically shells out $7500 roughly knowing full well rights price was considerably cheaper. He is positioned
I believe he is considering $3 million as a fact. He has time to alter the size he picks up, to keep concern real, but if he is doing it, this guy networks, my opinion he knows other rich buddies on the same page
I am very impressed on the bod member that signs point towards $3 million commitment. If $3 million does not impress, I understand entrenched issues, but somebody putting up $3 million in a big hint, you can read bio on delcath website. That is money to help put a company over the top
Over 1.5 million shares for an individual bod member is a lot of money, it could of course be fake but I don't think so. If it was collusion to fake, Simpson and Keck would have bought more as 100 shares is nothing with their well described generous salaries. So do you believe 4 fakers with individual approaches or ...
Whoa, stop the presses. That makes 4 insiders at least. Why the last 2 buy so much unless they are serious about rights, which is cheaper.
I believe rights for one of 500,000 shares and the other over 1.5 M shares if my arithmentic and reading skill are up to par today.
RS would not work, math does not support. 50,000 is slightly paltry, but if the offering was hopeless, a token gesture is silly. On the other hand, it may have been a requirement from some big boys. 50/50 seems right.
That makes 2 potential requirements behind the scenes, insider participation and acceleration of phase 3.
This all could have been in the works for months, again 50/50 story to me
That is one old assertion shot down I suppose. I suppose so far 2 from the team got in under the wire, so they could each have rights to 50,000 shares?
Makes it hard to call on how the rights offering is going to turn out. 50/50 between good offering or mediocre offering?
Hmm, I may have to participate with this signal.
I would love to see these guys proved completely wrong versus so far only partially wrong, I will be leading the pack in high praise if and when, otherwise just risk vs reward as always
Not so fast, if this is selling due to record date. I don't understand the selling that well at a price little above $1.75, but could make sense I suppose to a rights holder.
only thing I care about for now is seeing how much money company gets, but obviously it would not give a good feeling if the stock price gives way
It is unpredictable when trial will finish, but it is a lengthy process to submit and get approval. IF company gets the money soon, all is going to work out well. Show me the money
I just mean if the rights offering is done as described for xxx number of dollars, HB interference is not significant to the task at hand
Sturgis is a good destination but am unlikely to sail the 7 seas extensively with you and Mark Twain
Investors were never down on Ladd. I think the rights offering is for real but the amount raised is everything and HB stuff is unimportant unless HB interferes with offering
She was chief engineer on one of the worst performing stocks between late 2016 and late 2017 one could ever find, but what is done is done. What can we possibly learn new until the "rights" portrays
I suspect Simpson knows about Hobbs laying significant money on delcath in 2009. If this company reaches full enrollment in less than 12 months, she might surprise you
There is almost zero chance of approval for 2019, but what matters is whether the 50 million boys see the cup as full or empty. A good point was made about whether insiders buy, but if the company grosses $27 million by end of August, everything will look glowing. I have zero confidence, but will be first to praise if August end goes that way
Yes it could be seen as a race to bottom between Simpson and shareholders on this sore topic. If though phase 3 is completed on a high note, she will have cleverly gotten to the finish line like as a shrewd enough tortoise
To have merit all people who touched delcath other than a quick trade, have to acknowledge their poor assessment of fundamentals, timing. The true Queen, one and only, never ran a bluff such as touting imminent b/o, never said FDA approval in 2018, never said patents were worth $35 million. Well actually if she is running a bluff, it is getting $50 million, but all the big bucks lost were well before this rights talk
I may be the only one that sees the convertible in 2016 as similar to ATM financing, a fine idea if market cap is adequate, low market cap = drowning Goddess, Goddess needs money to live, all corporate deities do
An apologist is not needed for company doing what has to be done regarding phase 3 changes. You were doing okay dd trying to learn about recruitment sites, answers are not with FBI, lawyers, SEC imo. I have yet to see anybody contemplate embarrassment for voting NO
Europe can use product any way they wish and despite Germany providing some kind of public reimbursement, revenue is bad. I consider slow enrollment always as another negative indicator of potential revenue. I do agree though money issue needs to be solved although the company so far has taken on every obstacle to stay alive
Bond is living proof as why your analysis is bad. The most positive way to describe is enrollment by mid 2019, that sounds so much better than giving end dt for phase 3 or approval dt. Those are more hazy dates as well. The only problem is whether enrollment will be complete by then.
The real negative I repeat is it is questionable whether the external world is interested in CS. The currently dead message boards for once realistically parallel real world.
Low volume, low stock price, needed money, dead message boards, needed change to phase 3, "report neg news to discourage", 100 percent bad theory me thinks
There is only one queen here, who happens to work closely with the FDA and medical community. I view the only tool to wow the future, if adequate financing is OS, over all survival
Hopefully in 2019 there would be more knowledgeable medical types attracted to this board. A big OS in itself would be apparently good. I hope at least 1.5 year median.
Some would say this is a delay, but big money might see this as acceleration if they knew the scoop already. It would be nice if 240 patients were enrolled by the end of last month, I hope it was at least 50 in the CS arm. Simpson and FDA may be encouraged enough to believe the OS is a done deal winner, so half empty or half full, back to priority one the "BIG RIGHTS OFFERING"
I am feeling hopeful about the clinical trial change is smart business. The lack of interest for this technology is a lemon, but how much lemonade can come out, we continue to wait and ponder but …
If big financing completed, 2018 is going to end up being a good year and 2019 is going to be good